XIENCE SKYPOINT
Device
Abbott Laboratories
Total Payments
$476,969
Transactions
5,001
Doctors
1,679
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $360,429 | 2,663 | 1,035 |
| 2023 | $116,540 | 2,338 | 946 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $212,162 | 77 | 44.5% |
| Food and Beverage | $127,496 | 4,846 | 26.7% |
| Space rental or facility fees (teaching hospital only) | $58,081 | 14 | 12.2% |
| Consulting Fee | $41,900 | 25 | 8.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,900 | 3 | 5.8% |
| Travel and Lodging | $8,177 | 27 | 1.7% |
| Education | $1,252 | 9 | 0.3% |
Payments by Type
General
$264,807
4,924 transactions
Research
$212,162
77 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Abbott Vascular Medical Device Registry | Abbott Laboratories | $143,970 | 0 |
| A Clinical Investigation to Assess the Abbott Next Generation Drug Eluting Stent 48mm Everolimus Eluting Coronary Stent System (EECSS) in Treatment of de Novo Native Coronary Artery Disease | Abbott Laboratories | $44,279 | 0 |
| A Clinical Investigation to Assess the Abbott Next Generation Drug Eluting Stent 48mm Everolimus Eluting Coronary Stent System (EECSS) in Treatment of de Novo Native Coronary Artery Disease (SPIRIT 48) | Abbott Laboratories | $9,500 | 0 |
| A Clinical Investigation to Assess the Abbott Next Generation Drug Eluting Stent48mm | Abbott Laboratories | $7,703 | 0 |
| SPIRIT XLV PAS: XIENCE Skypoint Large Vessel Post Approval Study | Abbott Laboratories | $5,440 | 0 |
| AbbottVascularMedicalDevice Registry | Abbott Laboratories | $1,270 | 0 |
Top Doctors Receiving Payments for XIENCE SKYPOINT — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Chillicothe, OH | $587.29 | 48 |
| , MD | Interventional Cardiology | Morristown, NJ | $529.49 | 6 |
| , M.D | Interventional Cardiology | Sacramento, CA | $527.42 | 6 |
| , MD | Cardiovascular Disease | Voorhees, NJ | $527.15 | 34 |
| , MD | Cardiovascular Disease | Voorhees, NJ | $517.96 | 31 |
| , APN-C | Nurse Practitioner | Edison, NJ | $505.45 | 29 |
| , M.D | Interventional Cardiology | Burlington, VT | $502.77 | 2 |
| , M.D | Interventional Cardiology | Houston, TX | $478.76 | 7 |
| , PAC | Medical | Apopka, FL | $459.19 | 8 |
| , MD | Interventional Cardiology | Mechanicsville, VA | $458.01 | 11 |
| , M.D | Cardiovascular Disease | Edison, NJ | $452.50 | 23 |
| , MD | Cardiovascular Disease | Plainfield, NJ | $451.69 | 17 |
| , MD | Cardiovascular Disease | Kingsport, TN | $434.84 | 28 |
| , MD | Internal Medicine | Kingsport, TN | $418.70 | 31 |
| , MD | Interventional Cardiology | Middleburg Hts, OH | $407.09 | 7 |
| , D.O | Internal Medicine | Mountain Home, TN | $405.64 | 27 |
| , M.D | Internal Medicine | El Cajon, CA | $404.46 | 5 |
| , MD | Cardiovascular Disease | Charlotte, NC | $404.09 | 4 |
| , M.D | Internal Medicine | Columbus, OH | $402.61 | 28 |
| , MD | Interventional Cardiology | Kingsport, TN | $391.80 | 26 |
| , M.D | Cardiovascular Disease | Towson, MD | $385.34 | 10 |
| , M.D | Cardiovascular Disease | Humble, TX | $383.99 | 15 |
| , MD | Internal Medicine | Kingsport, TN | $383.07 | 24 |
| , FNP | Family | Kingsport, TN | $383.07 | 24 |
| , MD | Cardiovascular Disease | Kingsport, TN | $383.07 | 24 |
Ad
Manufacturing Companies
- Abbott Laboratories $476,969
Product Information
- Type Device
- Total Payments $476,969
- Total Doctors 1,679
- Transactions 5,001
About XIENCE SKYPOINT
XIENCE SKYPOINT is a device associated with $476,969 in payments to 1,679 healthcare providers, recorded across 5,001 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2023 to 2024. In 2024, $360,429 was paid across 2,663 transactions to 1,035 doctors.
The most common payment nature for XIENCE SKYPOINT is "Unspecified" ($212,162, 44.5% of total).
XIENCE SKYPOINT is associated with 6 research studies, including "Abbott Vascular Medical Device Registry" ($143,970).